Want to see SE:ITECH full AI Analyst Report?
I-Tech AB (ITECH) Stock Price & Analysis
ITECH Stock Chart & Stats
- Day’s Range
- SEK 57.70 - SEK 60.40
- 52-Week Range
- SEK 42.20 - SEK 80.80
- Previous Close
- SEK 58.70
- Volume
- 8,403
- Average Volume (3M)
- 34.98K
- Market Cap
- SEK 711.47M
- Enterprise Value
- SEK 648.23M
- Total Cash (Recent Filing)
- SEK 177.22M
- Total Debt (Recent Filing)
- SEK 0
- Price to Earnings (P/E)
- 14.0
- Beta
- -0.05
- Next Earnings
- Feb 04, 2027 (Est.)
- EPS Estimate
- 0.93
- Last Dividend Ex-Date
- May 22, 2026
- Dividend Yield
- 2.11%
Bulls Say, Bears Say
Bulls Say
High Profitability And Debt-free Balance Sheet
Strong profitability combined with essentially no leverage gives I-Tech financial resilience and flexibility. The debt-free balance sheet can support investment in products and markets while improving returns on shareholder capital, helping preserve earnings quality through normal business cycles.
Organic Growth And Customer Diversification
Continued organic growth indicates expanding adoption of Selektope, while broader contributions from smaller customers and Asian markets can reduce reliance on any single account. This combination supports a more durable revenue base and strengthens I-Tech’s market reach over coming quarters.
Large Underpenetrated Market With Expansion Potential
Low current penetration of the global commercial fleet leaves substantial room for wider Selektope adoption. Evaluation of complementary ingredients, new marine applications, and aquaculture could extend the company’s addressable market and create additional growth avenues beyond its established core.
Bears Say
EU Regulatory Re-registration Risk
A non-renewal would restrict the use and sale of Selektope-containing paint in the EU, creating a durable regulatory obstacle in an important market. Although management estimates roughly 5% of the addressable market would be affected, compliance costs and transition requirements could still weigh on execution.
Dependence On A Single Revenue-generating Product
Reliance on one commercial product concentrates I-Tech’s revenue exposure around Selektope’s demand, regulatory status, and adoption cycle. Planned products and technologies may eventually diversify the business, but their uncertain timing means that portfolio resilience remains limited over the next several quarters.
Margin Volatility And Weaker Free-cash-flow Trend
The sharp decline in gross margin indicates that cost pressure or product mix changes can materially affect profitability even while EBIT remains strong. The accompanying free-cash-flow contraction may reduce internally funded investment capacity and makes the durability of recent earnings performance less certain.
I-Tech AB News
ITECH FAQ
What was I-Tech AB’s price range in the past 12 months?
What is I-Tech AB’s market cap?
When is I-Tech AB’s upcoming earnings report date?
How were I-Tech AB’s earnings last quarter?
Is I-Tech AB overvalued?
Does I-Tech AB pay dividends?
What is I-Tech AB’s EPS estimate?
How many shares outstanding does I-Tech AB have?
What happened to I-Tech AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of I-Tech AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
I-Tech AB
I-Tech AB, a biotechnology firm established in Mölndal, Sweden, in 2000, focuses on creating and commercializing products to prevent biofouling. Their flagship innovation is Selektope, a unique bio-repellent ingredient engineered for marine coatings. This compound provides crucial protection against hard fouling on ships, primarily by temporarily stimulating the swimming behavior of barnacle larvae, thereby preventing them from attaching to coated surfaces. The company's primary clientele is the marine coatings industry.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Markus Jönsson
- Employees
- 11
- Website
- www.i-tech.se
- Address
- Förändringens gata 10, Mölndal, VG, 431 53, SE
I-Tech AB (ITECH) Earnings & Revenues
ITECH Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, with strong Q3 growth, higher profitability, a 60% gross margin, rising cash, favorable shipping-market indicators, and progress in product and market expansion. The main challenges were the uncertain EU re-registration of Selektope, elevated raw material prices, customer-driven revenue volatility, regulatory costs, and the early commercialization stage of the aquaculture technologies.
View all SE:ITECH earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 5 | 11 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 3 | 0 | 9 |
